editors-in-chief, J. Bogousslavsky and M. G. Hennerici, Jan/Feb 1991-, bimonthly, $289 (institutional), $144.50 (personal), New York, Karger.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In the editorial introducing the first issue, the editors indicate their intention to focus on clinical aspects of cerebrovascular disease. They further state that
... because the field of cerebrovascular diseases encompasses varied specialties, such as neurology, internal medicine, surgery, radiology, epidemiology, cardiology, hematology, psychology, or rehabilitation, we are confident that Cerebrovascular Diseases will be a journal of synthesis and alliances of opinions, be they consensus or controversy, instead of a catalogue of hyperspecialized articles.
This is a laudable goal but seems unlikely to be achieved given the sheer size of the literature on cerebrovascular disease. Cerebrovascular Diseases will publish 60 articles each year, while English-language clinical articles published annually on cerebrovascular diseases number about 2000. It is difficult to imagine how a relatively small journal that casts such a wide net can avoid the trap of becoming "a catalogue of hyperspecialized articles." In competing for space on the clinician's desk,
Morse DH, Weiner LP. Cerebrovascular Diseases. JAMA. 1992;267(5):731. doi:10.1001/jama.1992.03480050135045